speb/financial-data huggingface dataset:
CTX.TO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 45000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Inventory: 4051000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 15829000.00
CTX.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -2019000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 311000.00
CTX.TO balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 311000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 311000.00
CTX.TO balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 311000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Leases: 617000.00
CTX.TO balance_sheet (quarterly, 2024-12-31) — Leases: 617000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 365000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 365000.00
CTX.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -441000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 311000.00
CTX.TO balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 311000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 891000.00
CTX.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 891000.00
CTX.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -320000.00
CTX.TO income_statement (annual, 2024-12-31) — Net Income: -2750000.00
CTX.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -2750000.00
CTX.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -2750000.00
CTX.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -2750000.00
CTX.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -2750000.00
CTX.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -2750000.00
CTX.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -2750000.00
CTX.TO income_statement (annual, 2024-12-31) — Net Interest Income: 431000.00
CTX.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -441000.00
CTX.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -441000.00
CTX.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 431000.00
CTX.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -100000.00
CTX.TO cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -50000.00
CTX.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -912000.00
CTX.TO cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
CTX.TO balance_sheet (annual, 2024-12-31) — Net PPE: 2423000.00
CTX.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1107000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 14093000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 1388000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 614000.00
CTX.TO balance_sheet (quarterly, 2024-12-31) — Non Current Note Receivables: 614000.00
CTX.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: -1400000.00
CTX.TO income_statement (annual, 2024-12-31) — Normalized Income: -2816665.00
CTX.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 2725000.00
CTX.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -81000.00
CTX.TO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -64000.00
CTX.TO income_statement (annual, 2024-12-31) — Operating Income: -3215000.00
CTX.TO income_statement (annual, 2024-12-31) — Operating Revenue: 19580000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 19075540.00
CTX.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 50000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 1109000.00
CTX.TO income_statement (annual, 2024-12-31) — Other Gand A: 5446000.00
CTX.TO income_statement (annual, 2024-12-31) — Other Income Expense: 20000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1736000.00
CTX.TO balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 1736000.00
CTX.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -146000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 67000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Other Properties: 3453000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Other Receivables: 226000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 4996000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 264000.00
CTX.TO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 264000.00
CTX.TO income_statement (annual, 2024-12-31) — Pretax Income: -2764000.00
CTX.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
CTX.TO cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
CTX.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
CTX.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CTX.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1185000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 984000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Receivables: 1716000.00
CTX.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 9972000.00
CTX.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1366000.00
CTX.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -441000.00
CTX.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -320000.00
CTX.TO income_statement (annual, 2024-12-31) — Research And Development: 646000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -45349000.00
CTX.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 5365000.00
CTX.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 78000.00
CTX.TO cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
CTX.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 10811000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Share Issued: 19075540.00
CTX.TO income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
CTX.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 181000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 15829000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 14093000.00
CTX.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 335.00
CTX.TO income_statement (annual, 2024-12-31) — Tax Provision: -14000.00
CTX.TO income_statement (quarterly, 2024-12-31) — Tax Provision: -14000.00
CTX.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.01
CTX.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 133000.00
CTX.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 133000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Total Assets: 21776000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 15829000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Total Debt: 834000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 15829000.00
CTX.TO income_statement (annual, 2024-12-31) — Total Expenses: 22795000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 5947000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 6472000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 432000.00
CTX.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -3215000.00
CTX.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 67000.00
CTX.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 67000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Work In Process: 564000.00
CTX.TO balance_sheet (annual, 2024-12-31) — Working Capital: 9789000.00
CTX.TO income_statement (annual, 2024-12-31) — Write Off: 0.00
CTX.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 2632000.00
CTX.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 3537000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1506000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 7555000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -92000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Amortization: 27000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 27000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 63000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 19028110.00
CTX.TO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.05
CTX.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 9273000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -66000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 718000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 52486000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 8538000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 8538000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -159000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -66000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -513000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -1109000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 53000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1028000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 174000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 146000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -49000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -738000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 52486000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 14867000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -43000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1967000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 15546000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 474000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 474000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 6574000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 353000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 176000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 353000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 176000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 149000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 19028110.00
CTX.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.05
CTX.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -932000.00
CTX.TO income_statement (quarterly, 2025-03-31) — EBIT: -920000.00
CTX.TO income_statement (quarterly, 2025-03-31) — EBITDA: -567000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -14000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 14000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 3000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 8538000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -159000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 3067000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -579000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -1000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 56000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1107000.00
CTX.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2325000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1587000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1598000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2285000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 1570000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 12000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 12000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Interest Income: 100000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 100000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 8000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 5097000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 14867000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -66000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 297000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 297000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 244000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 244000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -116000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 297000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -43000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Net Income: -932000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -932000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -932000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -932000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -932000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -932000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -932000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 88000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -116000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -116000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 88000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 2285000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -66000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 13280000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 1419000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 622000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -623000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -988000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -513000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 14000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Operating Income: -1062000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 3537000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 19005492.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 344000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 50000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 1107000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 1066000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 42000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -186000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 71000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 2285000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 61000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 6050000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -932000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -66000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1557000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 1567000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1790000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 353000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -116000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -43000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Research And Development: 131000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -46281000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 1259000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2325000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 19005492.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 30000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 14867000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 13280000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CTX.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 21756000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 14867000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 718000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 14867000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 4599000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 6889000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 6210000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 315000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1062000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 56000.00
CTX.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 56000.00
CTX.TO cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -1000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Work In Process: 473000.00
CTX.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 8972000.00
CTX.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 3242000.00
CTX.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 6233000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2147000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 7807000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -92000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 73000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 18933912.00
CTX.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.04
CTX.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 8538000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -170000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 602000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 52190000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 8184000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 8184000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -175000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -170000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -3000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: 92000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -50000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -450000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -644000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -1052000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -648000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -348000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 52190000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 15612000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -59000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2408000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 15777000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 479000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 479000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 6076000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 353000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 353000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 353000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 353000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 353000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 19036714.00
CTX.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.04
CTX.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 798000.00
CTX.TO income_statement (quarterly, 2025-06-30) — EBIT: 810000.00
CTX.TO income_statement (quarterly, 2025-06-30) — EBITDA: 1163000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -4000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 4000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -6000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 8184000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -175000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 2489000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -173000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 18000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 100000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1098000.00
CTX.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2748000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1438000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 2239000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2302000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 3825000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 12000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 12000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Interest Income: 131000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 131000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 8000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 4932000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 15612000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -170000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 293000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 293000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 123000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 123000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -116000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 293000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -59000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Net Income: 798000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 798000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 798000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 798000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 798000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 798000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 798000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 119000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -116000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -116000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 119000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 2302000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -170000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 14174000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 1427000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 649000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1063000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 713000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -3000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 22000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Operating Income: 583000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 6233000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 18887760.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 394000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 50000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1098000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 1417000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 96000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -225000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 75000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 2302000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 120000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5547000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 798000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -170000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 2070000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 2267000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2408000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 353000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -116000.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -59000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Research And Development: 141000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -45483000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 1331000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2748000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 18887760.00
CTX.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 28000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 15612000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 14174000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 15000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
CTX.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 21886000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 15612000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 602000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 15612000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 5650000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 6274000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 6109000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 198000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 583000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 100000.00
CTX.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 100000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Work In Process: 373000.00
CTX.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 9701000.00
CTX.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 3017000.00
CTX.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 5393000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1727000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 8401000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -92000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 353000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 18836693.00
CTX.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.04
CTX.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 8184000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -46000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 484000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 51489000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 8308000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 8308000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -239000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -821000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1173000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -149000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -9000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 481000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 383000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 706000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 383000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 113000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 51489000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 16256000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -121000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2538000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 15985000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 484000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 484000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5121000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 384000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 384000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 384000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 384000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 18848861.00
CTX.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.04
CTX.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 753000.00
CTX.TO income_statement (quarterly, 2025-09-30) — EBIT: 763000.00
CTX.TO income_statement (quarterly, 2025-09-30) — EBITDA: 1147000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -12000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 12000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 11000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 8308000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -239000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 3220000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 1127000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
CTX.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -289000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 1096000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1631000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 1819000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2122000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 2855000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 10000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 10000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Interest Income: 38000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 38000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 6000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 5363000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 16256000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -821000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 0.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 0.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 0.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 0.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -118000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 0.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -121000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Net Income: 753000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 753000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 753000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 753000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 753000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 753000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 753000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 28000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -118000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -118000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 28000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -775000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 2122000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -46000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 14625000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 1418000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 300000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1717000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 1237500.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1173000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 12000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Operating Income: -162000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 5393000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 18613938.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 403000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 50000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 1096000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 887000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -1042000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 79000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 1469000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 2122000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 184000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4587000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 753000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -46000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 1456000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 1911000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2538000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 384000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -118000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -121000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Research And Development: 138000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -44730000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
CTX.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2495000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 18613938.00
CTX.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: -281000.00
CTX.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 7000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 16256000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 14625000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -85500.00
CTX.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
CTX.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 21456000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 16256000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 484000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 16256000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 5555000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 5200000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5471000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 79000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -162000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -570000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -570000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Work In Process: 687000.00
CTX.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 10864000.00
CTX.TO income_statement (quarterly, 2025-09-30) — Write Off: 281000.00
CTX.TO income_statement (annual, 2025-12-31) — +Operating Expense: 12131000.00
CTX.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 3063000.00
CTX.TO income_statement (annual, 2025-12-31) — +Total Revenue: 21118000.00
CTX.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 5955000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1840000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1840000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -2987000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2987000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 8409000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 8409000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -76000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -76000.00
CTX.TO cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 617000.00
CTX.TO cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 617000.00
CTX.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 522000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 33000.00
CTX.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 18851984.00
CTX.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.00
CTX.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 9273000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 8308000.00
CTX.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -333000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -51000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 334000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 334000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 51489000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 51489000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 8577000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 8577000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8577000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8577000.00
CTX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -788000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -215000.00
CTX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -973000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 84000.00
CTX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1073000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 416000.00
CTX.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -558000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 608000.00
CTX.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 59000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 65000.00
CTX.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 859000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -200000.00
CTX.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -177000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -90000.00
CTX.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 183000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 383000.00
CTX.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -404000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -90000.00
CTX.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -688000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 285000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Common Stock: 51489000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 51489000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 15576000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 15576000.00
CTX.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -223000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
CTX.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 10009000.00
CTX.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3273000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Current Assets: 15718000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 15718000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 334000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 334000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 334000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 334000.00
CTX.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 4719000.00
CTX.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 4719000.00
CTX.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 9000.00
CTX.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 9000.00
CTX.TO cash_flow (annual, 2025-12-31) — Depreciation: 884000.00
CTX.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1501000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 411000.00
CTX.TO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 736000.00
CTX.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: -354000.00
CTX.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1501000.00
CTX.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 411000.00
CTX.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 736000.00